Form 8-K NEUROCRINE BIOSCIENCES For: Dec 12
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/23/2026
- Nasdaq reaches record high close, AI stocks rally
- Meta AI agent triggers heavy selloff in banks, insurers, and travel stocks
- Exclusive: SB Energy Nasdaq IPO moving forward as planned
- AI and earnings keep driving markets as focus shifts to Trump-Xi summit
- Meta bull case increasingly playing out, Mizuho says
Neurocrine Bio. (NBIX) PT Lowered to $102 at H.C. Wainwright
December 13, 2018 11:09 AM ESTH.C. Wainwright analyst Andrew Fein lowered the price target on Neurocrine Bio. (NASDAQ: NBIX) to $102.00 (from $162.00) while maintaining a Buy rating.
... MoreNeurocrine Bio. (NBIX) PT Lowered to $96 at Baird, Removed from 'Fresh Pick' List
December 12, 2018 12:16 PM ESTBaird analyst Brian Skorney lowered the price target on Neurocrine Bio. (NASDAQ: NBIX) to $96.00 (from $131.00) while maintaining an Outperform rating and removed the Fresh Pick designation on Tourette failure.
As a result, the firm is reducing their peak sales estimate for... More
